Resuscitation
Volume 66, Issue 2 , Pages 225-230 , August 2005

Report of a patient with severe transfusion-related acute lung injury after multiple transfusions, resuscitated with albumin

  • Alimorad G. Djalali

      Affiliations

    • Department of Anesthesiology, Perioperative Pain Medicine and Intensive Care, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Kimberly A. Moore

      Affiliations

    • Department of Surgery, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
    • ,
  • Edward Kelly

      Affiliations

    • Division of General and Gastrointestinal Surgery, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA

Received 5 December 2004 ,Revised 1 February 2005 ,Accepted 1 February 2005.

References 

  1. Rizk A, Gorson KC, Kenny L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion. 2001;41:264–268
  2. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573–577
  3. Weber JG, Warner MA, Moore SB. What is the incidence of perioperative transfusion-related acute lung injury?. Anesthesiology. 1995;82:789
  4. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44:1774–1789
  5. Lee JH. Transfusion-related fatalities. Reports to US FDA, 1990–1998. ABC Newsletter, 1 October, 1999.
  6. US Food and Drug Administration. Avoiding deaths from blood transfusions. FDA patient safety news, Show #32, October 2004. www.fda.org.
  7. Kopko PM. Holland PV: transfusion-related acute lung injury. Br J Haematol. 1999;105:322–329
  8. Kopko PM, Popovsky MA, MacKenzie MR. Human leukocyte antigen class II antibodies in transfusion-related acute lung injury. Transfusion. 2001;42:1244–1248
  9. Guglin M, Dey C, Meny GM, Sultan W. Pulmonary edema after transfusion in a patient with end-stage renal disease. Clin Nephrol. 2003;59:475–479
  10. Eastland T, McGrath PC, Britten A, Propp R. Fatal pulmonary transfusion reaction to plasma containing donor HLA antibodies. Vox Sang. 1989;57:63–66
  11. Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H. Prevalence of HLA sensitization in female apheresis donors. Transfusion. 1999;39:103–106
  12. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997;37:719–726
  13. Boshkov LK, Mehdizadehkashi Z, Alcorn J. Failure to implicate anti-granulocyte or anti-HLA class I or class II antibodies as the major pathogenetic mechanism in a series of transfusion-associated acute lung injury cases (TRALI). Blood. 2001;98:828A
  14. Dubois M, Lotze MT, Diamond WJ, Kim YD, Flye MW, et al. Pulmonary shunting during leukoagglutinnin-induced noncardiac pulmonary edema. JAMA. 1980;244:2186–2189
  15. Anderson BO, Brown JM, Bensard DD, Grosso MA, Banerjee A. Reversible lung neutrophil accumulation can cause lung injury by elastase-mediated mechanisms. Surgery. 1990;108:262–268
  16. Westaby S. Mechanism of membrane damage and surfactant depletion in acute lung injury. Intensive Care Med. 1986;12:2–5
  17. Nouraei SM, Wallis JP, Bolton DT, Hasan A. Management of transfusion related acute lung injury with extracorporeal cardiopulmonary support in a 4-year-old child. Br J Anaesth. 2003;91:292–294
  18. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85:599–610
  19. Demling RH. Effect of plasma and interstitial protein content on tissue edema formation. Curr Stud Hematol Blood Transfus. 1986;53:36–52
  20. Quinlan GJ, Mumby S, Martin GS, Bernard GR. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med. 2004;32:755–759
  21. Kaag MM. Maintenance of adequate serum albumin during extended surgery seems beneficial. Electron BMJ, 12 August, 1998. http://www.bmj.com/cgi/eletters/317/7153/235#EL 15.
  22. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997;50:693–703
  23. Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med. 2002;30:2175–2182
  24. Soni N. Wonderful albumin. BMJ. 1995;310:887–888
  25. Fleck A, Raines G, Hawker F, Trotter J, Wallace P. Increased vascular permeability: a major cause of hypoalbuminemia in disease and injury. Lancet. 1985;1(8432):781–784
  26. Stockwell MA, Scott A, Day A, Riley B, Soni N. Colloid solutions in the critically ill. A randomized comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia. 1992;47:7–9
  27. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. SAFE study investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–2256
  28. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systemic review of randomized controlled trials. BMJ 1998;317:235–240.
  29. Alving BM, Hojima Y, Pisano JJ, Mason BL. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med. 1978;299:66–70
  30. Nohe B, Dieterich H-J, Eichner M, Unertl K. Certain batches of albumin solutions influence the expression of endothelial cell adhesion molecules. Intensive Care Med. 1999;25:1381–1385
  31. Progar JJ, May JC, Rains TC, Watters RL, Yu L. Preparation of an intra-laboratory reference material. Determination of the aluminum content of a pooled 5% albumin (human) solution by ETAAS, MFS and ICP-AES. Biologicals. 1996;24:87–93
  32. McEvoy GK. AHFS Drug Information. Bathesda: American Society of Health-System Pharmacists Inc.; 2002;
  33. Yamey G. Albumin industry launches global promotion. BMJ. 2000;320:533

☆ A Spanish translated version of the Abstract and Keywords of this article appears as Appendix at 10.1016/j.resuscitation.2005.02.004.

☆☆ The patient in the case report was treated at Brigham and Women's Hospital.

PII: S0300-9572(05)00121-8

doi: 10.1016/j.resuscitation.2005.02.004

Resuscitation
Volume 66, Issue 2 , Pages 225-230 , August 2005

Article Tools

* Image Usage & Resolution